Prosecution Insights
Last updated: April 19, 2026

Shenzhen Hyperway Pharmaceuticals Co. Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18320048 BENZYLAMINE OR BENZYL ALCOHOL DERIVATIVE AND USES THEREOF ANDERSON, REBECCA L 1626 Non-Final OA May 18, 2023
18014157 COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF KWON, YONG SOK 1613 Non-Final OA Dec 31, 2022
18014156 COMPOUND SERVING AS BTK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF HERNANDEZ, JACKSON J 1627 Final Rejection Dec 31, 2022

Managing Shenzhen Hyperway Pharmaceuticals Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month